Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease

Clinical Science

Volumn 123, Issue 10, 2012, Pages 601-610

  von Haehling, Stephan ^a   Papassotiriou, Jana ^b   Hartmann, Oliver ^b   Doehner, Wolfram ^a   Stellos, Konstantinos ^c   Geisler, Tobias ^d   Wurster, Thomas ^d   Schuster, Andreas ^e   Botnar, Rene M ^e   Gawaz, Meinrad ^d   Bigalke, Boris ^d,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Biotechnology Centre Hennigsdorf   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary artery disease; Mid regional pro atrial natriuretic peptide (MR proANP); Natriuretic peptide; Prognostic biomarker; Troponin I

Indexed keywords

ATRIAL NATRIURETIC FACTOR DERIVATIVE; MID REGIONAL PRO ATRIAL NATRIURETIC PEPTIDE; TROPONIN I; UNCLASSIFIED DRUG; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; MIDREGIONAL PRO ATRIAL NATRIURETIC PEPTIDE, HUMAN; MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE, HUMAN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; TELECONSULTATION; BLOOD; EVALUATION; FOLLOW UP; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGINA, STABLE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; ROC CURVE; SURVIVAL ANALYSIS; TROPONIN I;

EID: 84866791491     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120216     Document Type: Article

References (38)

1. Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P. and Braunwald, E. (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105, 1760-1763
2. James, S. K., Lindahl, B., Siegbahn, A., Stridsberg, M., Venge, P., Armstrong, P., Barnathan, E. S., Califf, R., Topol, E. J., Simoons, M. L. et al. (2003) N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108, 275-281
3. Morrow, D. A., Sabatine, M. S., Brennan, M. L., de Lemos, J. A., Murphy, S. A., Ruff, C. T., Rifai, N., Cannon, C. P. and Hazen, S. L. (2008) Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur. Heart. J. 29, 1096-10102
4. Tousoulis, D., Kampoli, A. M., Stefanadi, E., Antoniades, C., Siasos, G., Papavassiliou, A. G. and Stefanadis, C. (2008) New biochemical markers in acute coronary syndromes. Curr. Med. Chem. 15, 1288-1296
5. Brügger-Andersen, T., Aarsetøy, H., Grundt, H., Staines, H. and Nilsen, D. W. (2008) The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thromb. Res. 123, 60-66
6. Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W. et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29, 2388-2442
7. Jourdain, P., Jondeau, G., Funck, F., Gueffet, P., Le Helloco, A., Donal, E., Aupetit, J. F., Aumont, M. C., Galinier, M. and Eicher, J. C. (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J. Am. Coll. Cardiol. 49, 1733-1739
8. Lainchbury, J. G., Troughton, R. W., Strangman, K. M., Frampton, C. M., Pilbrow, A., Yandle, T. G., Hamid, A. K., Nicholls, M. G. and Richards, A. M. (2009) N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J. Am. Coll. Cardiol. 55, 53-60
9. Kurz, K., Schild, C., Isfort, P., Katus, H. A. and Giannitsis, E. (2009) Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction. Clin. Res. Cardiol. 98, 94-100
10. Schaub, N., Reichlin, T., Meune, C., Twerenbold, R., Haaf, P., Hochholzer, W., Niederhauser, N., Bosshard, P., Stelzig, C., Freese, M. et al. (2012) Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin. Chem. 58, 246-256
11. Viswanathan, K., Kilcullen, N., Morrell, C., Thistlethwaite, S. J., Sivananthan, M. U., Hassan, T. B., Barth, J. H. and Hall, A. S. (2010) Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J. Am. Coll. Cardiol. 55, 2590-2598
12. Amodio, G., Antonelli, G. and Di Serio, F. (2010) Cardiac biomarkers in acute coronary syndromes: a review. Curr. Vasc. Pharmacol. 8, 388-393
13. Omland, T., Aakvaag, A., Bonarjee, V. V., Caidahl, K., Lie, R. T., Nilsen, D. W., Sundsfjord, J. A. and Dickstein, K. (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93, 1963-1969
14. Morgenthaler, N. G., Struck, J., Thomas, B. and Bergmann, A. (2004) Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin. Chem. 50, 234-236
15. Maisel, A., Mueller, C., Nowak, R., Peacock, W. F., Landsberg, J. W., Ponikowski, P., Mockel, M., Hogan, C., Wu, A. H., Richards, M. et al. (2010) Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea results from the BACH (Biomarkers in Acute Heart Failure) Trial. J. Am. Coll. Cardiol. 55, 2062-2076
16. von Haehling, S., Jankowska, E. A., Morgenthaler, N. G., Vassanelli, C., Zanolla, L., Rozentryt, P., Filippatos, G. S., Doehner, W., Koehler, F., Papassotiriou, J. et al. (2007) Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J. Am. Coll. Cardiol. 50, 1973-1980
17. Sellitti, D. F., Koles, N. and Mendonça, M. C. (2011) Regulation of C-type natriuretic peptide expression. Peptides 32, 1964-1971
18. Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, Jr, D. E., Chavey, II, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N. et al. (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116, e148-e304
19. Thygesen, K., Alpert, J. S. and White, H. D. (2007) Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur. Heart J. 28, 2525-2538
20. Thomas, L., Müller, M., Schumann, G., Weidemann, G., Klein, G., Lunau, S., Pick, K. H. and Sonntag, O. (2005) Consensus of DGKL and VDGH for interim reference intervals on enzymes in serum. J. Lab. Med. 29, 301-308
21. McGeechan, K., Macaskill, P., Irwig, L., Liew, G. and Wong, T. Y. (2008) Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch. Intern. Med. 168, 2304-2310
22. Granger, C. B., Goldberg, R. J., Dabbous, O., Pieper, K. S., Eagle, K. A., Cannon, C. P., Van De Werf, F., Avezum, A., Goodman, S. G., Flather, M. D. et al. (2003) Global registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch. Intern. Med. 163, 2345-2353
23. Heagerty, P. J., Lumley, T. and Pepe, M. S. (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56, 337-344
24. Eggers, K. M., Oldgren, J., Nordenskjöld, A. and Lindahl, B. (2004) Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am. Heart J. 148, 574-581
25. Reichlin, T., Hochholzer, W., Bassetti, S., Steuer, S., Stelzig, C., Hartwiger, S., Biedert, S., Schaub, N., Buerge, C., Potocki, M. et al. (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361, 858-867
26. Keller, T., Zeller, T., Peetz, D., Tzikas, S., Roth, A., Czyz, E., Bickel, C., Baldus, S., Warnholtz, A. and Fröhlich, M. (2009) Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361, 868-877
27. Bigalke, B., Lindemann, S., Ehlers, R., Seizer, P., Daub, K., Langer, H., Schonberger, T., Kremmer, E., Siegel-Axel, D., May, A. E. et al. (2006) Expression of platelet collagen receptor VI is associated with acute coronary syndrome. Eur. Heart J. 27, 2165-2169
28. Bigalke, B., Geisler, T., Stellos, K., Langer, H., Daub, K., Kremmer, E., Seizer, P., May, A. E., Lindemann, S. and Gawaz, M. (2008) Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am. Heart J. 156, 193-200
29. Bigalke, B., Stellos, K., Geisler, T., Kremmer, E., Seizer, P., May, A. E., Lindemann, S., Melms, A., Luft, A. and Gawaz, M. (2010) Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke. Eur. J. Neurol. 17, 111-117
30. Bigalke, B., Stellos, K., Geisler, T., Lindemann, S., May, A. E. and Gawaz, M. (2010) Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease. Clin. Res. Cardiol. 99, 227-233
31. Hayashi, M., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Tsutsui, T., Horie, H., Ohnishi, M. and Kinoshita, M. (2001) Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J. Am. Coll. Cardiol. 37, 1820-1826
32. van Hateren, K. J., Alkhalaf, A., Kleefstra, N., Groenier, K. H., de Jong, P. E., de Zeeuw, D., Gans, R. O., Struck, J., Bilo, H. J., Gansevoort, R. T. et al. (2011) Comparison of the capabilities of a midregional fragment of the pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events. Clin. Chem. 58, 293-297
33. Khan, S. Q., Dhillon, O., Kelly, D., Squire, I. B., Struck, J., Quinn, P., Morgenthaler, N. G., Bergmann, A., Davies, J. E. and Ng, L. L. (2008) Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J. Am. Coll. Cardiol. 51, 1857-1564
34. Fan, J., Upadhye, S. and Worster, A. (2006) Understanding receiver operating characteristic (ROC) curves. Can. J. Emerg. Med. 8, 19-20
35. Grzybowski, M. and Younger, J. G. (1997) Statistical methodology: III. Receiver operating characteristic (ROC) curves. Acad. Emerg. Med. 4, 818-826
36. Hlatky, M. A., Greenland, P., Arnett, D. K., Ballantyne, C. M., Criqui, M. H., Elkind, M. S., Go, A. S., Harrell, Jr, F. E., Hong, Y., Howard, B. V. et al. (2009) American Heart Association expert panel on subclinical atherosclerotic diseases and emerging risk factors and the stroke council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119, 2408-2416
37. Ikonomidis, I., Stamatelopoulos, K., Lekakis, J., Vamvakou, G. D. and Kremastinos, D. T. (2008) Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 199, 3-11
38. Schnabel, R. B., Schulz, A., Messow, C. M., Lubos, E., Wild, P. S., Zeller, T., Sinning, C. R., Rupprecht, H. J., Bickel, C. and Peetz, D. (2010) Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur. Heart J. 31, 3024-3031